DC
CABA icon

Diametric Capital’s Cabaletta Bio CABA Stock Holding History

Diametric Capital’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Sell
135,598
-127,233
-48% -$418K 0.04% 348
2026
Q1 		$707K Buy
+262,831
New +$730K 0.18% 147
2023
Q2 		– Sell
-10,966
Closed -$90.7K – 365
2023
Q1 		$90.7K Buy
+10,966
New +$103K 0.04% 271

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Diametric Capital's CABA Position: Q2 2026 in Review

Diametric Capital reduced its Cabaletta Bio (CABA) stake by 48% in Q2 2026, selling an estimated $418K and leaving 135,598 shares worth $422K. The position accounts for 0.04% of the portfolio, ranked #348.

Diametric Capital first reported a position in CABA in Q1 2023 and has held it in 3 quarters since. The position peaked at $707K in Q1 2026. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Diametric Capital held 135,598 shares of Cabaletta Bio worth $422K as of Q2 2026.
  • Diametric Capital sold 127,233 Cabaletta Bio shares in Q2 2026, an estimated $418K.
  • Cabaletta Bio made up 0.04% of Diametric Capital's portfolio in Q2 2026, its #348 holding.
  • Diametric Capital first reported a position in Cabaletta Bio in Q1 2023 and has held it in 3 quarters since.
  • Diametric Capital's Cabaletta Bio position peaked at $707K in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.